Global OAB Treatment Market Research Report 2023
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OAB Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Anticholinergics
1.2.3 Mirabegron
1.2.4 Botox
1.2.5 Others
1.3 Market by Application
1.3.1 Global OAB Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OAB Treatment Market Perspective (2018-2029)
2.2 OAB Treatment Growth Trends by Region
2.2.1 Global OAB Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OAB Treatment Historic Market Size by Region (2018-2023)
2.2.3 OAB Treatment Forecasted Market Size by Region (2024-2029)
2.3 OAB Treatment Market Dynamics
2.3.1 OAB Treatment Industry Trends
2.3.2 OAB Treatment Market Drivers
2.3.3 OAB Treatment Market Challenges
2.3.4 OAB Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OAB Treatment Players by Revenue
3.1.1 Global Top OAB Treatment Players by Revenue (2018-2023)
3.1.2 Global OAB Treatment Revenue Market Share by Players (2018-2023)
3.2 Global OAB Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OAB Treatment Revenue
3.4 Global OAB Treatment Market Concentration Ratio
3.4.1 Global OAB Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OAB Treatment Revenue in 2022
3.5 OAB Treatment Key Players Head office and Area Served
3.6 Key Players OAB Treatment Product Solution and Service
3.7 Date of Enter into OAB Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OAB Treatment Breakdown Data by Type
4.1 Global OAB Treatment Historic Market Size by Type (2018-2023)
4.2 Global OAB Treatment Forecasted Market Size by Type (2024-2029)
5 OAB Treatment Breakdown Data by Application
5.1 Global OAB Treatment Historic Market Size by Application (2018-2023)
5.2 Global OAB Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OAB Treatment Market Size (2018-2029)
6.2 North America OAB Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OAB Treatment Market Size by Country (2018-2023)
6.4 North America OAB Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OAB Treatment Market Size (2018-2029)
7.2 Europe OAB Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OAB Treatment Market Size by Country (2018-2023)
7.4 Europe OAB Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OAB Treatment Market Size (2018-2029)
8.2 Asia-Pacific OAB Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OAB Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific OAB Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OAB Treatment Market Size (2018-2029)
9.2 Latin America OAB Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OAB Treatment Market Size by Country (2018-2023)
9.4 Latin America OAB Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OAB Treatment Market Size (2018-2029)
10.2 Middle East & Africa OAB Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OAB Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa OAB Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie OAB Treatment Introduction
11.1.4 AbbVie Revenue in OAB Treatment Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma OAB Treatment Introduction
11.2.4 Astellas Pharma Revenue in OAB Treatment Business (2018-2023)
11.2.5 Astellas Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OAB Treatment Introduction
11.3.4 Pfizer Revenue in OAB Treatment Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva OAB Treatment Introduction
11.4.4 Teva Revenue in OAB Treatment Business (2018-2023)
11.4.5 Teva Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson OAB Treatment Introduction
11.5.4 Johnson & Johnson Revenue in OAB Treatment Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Kyorin Pharmaceutical
11.6.1 Kyorin Pharmaceutical Company Detail
11.6.2 Kyorin Pharmaceutical Business Overview
11.6.3 Kyorin Pharmaceutical OAB Treatment Introduction
11.6.4 Kyorin Pharmaceutical Revenue in OAB Treatment Business (2018-2023)
11.6.5 Kyorin Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global OAB Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Anticholinergics
Table 3. Key Players of Mirabegron
Table 4. Key Players of Botox
Table 5. Key Players of Others
Table 6. Global OAB Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global OAB Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global OAB Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global OAB Treatment Market Share by Region (2018-2023)
Table 10. Global OAB Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global OAB Treatment Market Share by Region (2024-2029)
Table 12. OAB Treatment Market Trends
Table 13. OAB Treatment Market Drivers
Table 14. OAB Treatment Market Challenges
Table 15. OAB Treatment Market Restraints
Table 16. Global OAB Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global OAB Treatment Market Share by Players (2018-2023)
Table 18. Global Top OAB Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OAB Treatment as of 2022)
Table 19. Ranking of Global Top OAB Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by OAB Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players OAB Treatment Product Solution and Service
Table 23. Date of Enter into OAB Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global OAB Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global OAB Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global OAB Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global OAB Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global OAB Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global OAB Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global OAB Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global OAB Treatment Revenue Market Share by Application (2024-2029)
Table 33. North America OAB Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America OAB Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America OAB Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe OAB Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe OAB Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe OAB Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific OAB Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific OAB Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific OAB Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America OAB Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America OAB Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America OAB Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa OAB Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa OAB Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa OAB Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. AbbVie Company Detail
Table 49. AbbVie Business Overview
Table 50. AbbVie OAB Treatment Product
Table 51. AbbVie Revenue in OAB Treatment Business (2018-2023) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Astellas Pharma Company Detail
Table 54. Astellas Pharma Business Overview
Table 55. Astellas Pharma OAB Treatment Product
Table 56. Astellas Pharma Revenue in OAB Treatment Business (2018-2023) & (US$ Million)
Table 57. Astellas Pharma Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer OAB Treatment Product
Table 61. Pfizer Revenue in OAB Treatment Business (2018-2023) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. Teva Company Detail
Table 64. Teva Business Overview
Table 65. Teva OAB Treatment Product
Table 66. Teva Revenue in OAB Treatment Business (2018-2023) & (US$ Million)
Table 67. Teva Recent Development
Table 68. Johnson & Johnson Company Detail
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson OAB Treatment Product
Table 71. Johnson & Johnson Revenue in OAB Treatment Business (2018-2023) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Kyorin Pharmaceutical Company Detail
Table 74. Kyorin Pharmaceutical Business Overview
Table 75. Kyorin Pharmaceutical OAB Treatment Product
Table 76. Kyorin Pharmaceutical Revenue in OAB Treatment Business (2018-2023) & (US$ Million)
Table 77. Kyorin Pharmaceutical Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of FiguresFigure 1. Global OAB Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global OAB Treatment Market Share by Type: 2022 VS 2029
Figure 3. Anticholinergics Features
Figure 4. Mirabegron Features
Figure 5. Botox Features
Figure 6. Others Features
Figure 7. Global OAB Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global OAB Treatment Market Share by Application: 2022 VS 2029
Figure 9. Idiopathic Overactive Bladder Case Studies
Figure 10. Neurogenic Overactive Bladder Case Studies
Figure 11. OAB Treatment Report Years Considered
Figure 12. Global OAB Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global OAB Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global OAB Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global OAB Treatment Market Share by Players in 2022
Figure 16. Global Top OAB Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OAB Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by OAB Treatment Revenue in 2022
Figure 18. North America OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America OAB Treatment Market Share by Country (2018-2029)
Figure 20. United States OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe OAB Treatment Market Share by Country (2018-2029)
Figure 24. Germany OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific OAB Treatment Market Share by Region (2018-2029)
Figure 32. China OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America OAB Treatment Market Share by Country (2018-2029)
Figure 40. Mexico OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa OAB Treatment Market Share by Country (2018-2029)
Figure 44. Turkey OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia OAB Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. AbbVie Revenue Growth Rate in OAB Treatment Business (2018-2023)
Figure 47. Astellas Pharma Revenue Growth Rate in OAB Treatment Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in OAB Treatment Business (2018-2023)
Figure 49. Teva Revenue Growth Rate in OAB Treatment Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in OAB Treatment Business (2018-2023)
Figure 51. Kyorin Pharmaceutical Revenue Growth Rate in OAB Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed